AU2003228516A1 - Occlusive composition comprising a poly (2-cyanoacrylate) monomer - Google Patents

Occlusive composition comprising a poly (2-cyanoacrylate) monomer

Info

Publication number
AU2003228516A1
AU2003228516A1 AU2003228516A AU2003228516A AU2003228516A1 AU 2003228516 A1 AU2003228516 A1 AU 2003228516A1 AU 2003228516 A AU2003228516 A AU 2003228516A AU 2003228516 A AU2003228516 A AU 2003228516A AU 2003228516 A1 AU2003228516 A1 AU 2003228516A1
Authority
AU
Australia
Prior art keywords
cyanoacrylate
monomer
poly
occlusive composition
provides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003228516A
Other languages
English (en)
Inventor
Stephen C. Porter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston Scientific Corp
Original Assignee
Scimed Life Systems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scimed Life Systems Inc filed Critical Scimed Life Systems Inc
Publication of AU2003228516A1 publication Critical patent/AU2003228516A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/23—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and carboxyl groups, other than cyano groups, bound to the same unsaturated acyclic carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/06—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/36—Materials or treatment for tissue regeneration for embolization or occlusion, e.g. vaso-occlusive compositions or devices

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Surgery (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Reproductive Health (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Adhesives Or Adhesive Processes (AREA)
AU2003228516A 2002-04-12 2003-04-10 Occlusive composition comprising a poly (2-cyanoacrylate) monomer Abandoned AU2003228516A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/121,634 2002-04-12
US10/121,634 US7341716B2 (en) 2002-04-12 2002-04-12 Occlusive composition
PCT/US2003/011404 WO2003087042A1 (en) 2002-04-12 2003-04-10 Occlusive composition comprising a poly (2-cyanoacrylate) monomer

Publications (1)

Publication Number Publication Date
AU2003228516A1 true AU2003228516A1 (en) 2003-10-27

Family

ID=28790376

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003228516A Abandoned AU2003228516A1 (en) 2002-04-12 2003-04-10 Occlusive composition comprising a poly (2-cyanoacrylate) monomer

Country Status (9)

Country Link
US (1) US7341716B2 (enExample)
EP (1) EP1494999B1 (enExample)
JP (1) JP4504026B2 (enExample)
AT (1) ATE328865T1 (enExample)
AU (1) AU2003228516A1 (enExample)
CA (1) CA2481365C (enExample)
DE (1) DE60305906T2 (enExample)
ES (1) ES2261934T3 (enExample)
WO (1) WO2003087042A1 (enExample)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6037366A (en) * 1997-09-11 2000-03-14 Prohold Medical Technologies, Inc. Composition for creating vascular occlusions
AU2002316053A1 (en) * 2001-05-01 2002-11-11 A.V. Topchiev Institute Of Petrochemical Synthesis Two-phase, water-absorbent bioadhesive composition
WO2004035022A2 (en) * 2002-10-15 2004-04-29 Microtherapeutics, Inc. Prepolymeric materials for site specific delivery to the body
ES2311803T3 (es) * 2003-02-26 2009-02-16 Micro Therapeutics Inc Composiciones embolicas de silicie pirogena.
EP1708763A4 (en) * 2004-01-07 2011-03-23 Trivascular Inc METHODS, COMPOSITIONS, AND DEVICES FOR EMBOLIZING BODY LIGHTS
US9238127B2 (en) 2004-02-25 2016-01-19 Femasys Inc. Methods and devices for delivering to conduit
US8048086B2 (en) 2004-02-25 2011-11-01 Femasys Inc. Methods and devices for conduit occlusion
US8052669B2 (en) 2004-02-25 2011-11-08 Femasys Inc. Methods and devices for delivery of compositions to conduits
US8048101B2 (en) 2004-02-25 2011-11-01 Femasys Inc. Methods and devices for conduit occlusion
US20050287216A1 (en) * 2004-06-29 2005-12-29 Loomis Gary L Medical imaging agents for injectable compositions
US7201918B2 (en) * 2004-11-16 2007-04-10 Microvention, Inc. Compositions, systems and methods for treatment of defects in blood vessels
US7341392B2 (en) * 2005-04-22 2008-03-11 Dofair Co., Ltd. Lock device in an articulated joint for a foldable ladder
CA2619886C (en) 2005-08-17 2016-01-19 Ann Beal Salamone Conformable solvent-based bandage and coating material
PL2021043T3 (pl) * 2006-05-26 2011-06-30 Baxter Int Wstrzykiwalny wypełniacz pustych przestrzeni w kościach
JP5298010B2 (ja) * 2006-05-26 2013-09-25 バクスター・インターナショナル・インコーポレイテッド 骨造成のための注射用フィブリン組成物
ES2381448T3 (es) * 2007-03-26 2012-05-28 Baxter International Inc. Material de relleno de huecos inyectable par el aumento de tejidos blandos
EP2155107B1 (en) * 2007-04-12 2016-04-13 The University of Akron Injectible cyanoacrylate-functionalized polyisobutylenes
EP2326255B1 (en) * 2008-05-19 2020-05-06 Anaesthetic Care Limited Varicose vein treatment
US12171463B2 (en) 2008-10-03 2024-12-24 Femasys Inc. Contrast agent generation and injection system for sonographic imaging
US10070888B2 (en) 2008-10-03 2018-09-11 Femasys, Inc. Methods and devices for sonographic imaging
US9554826B2 (en) 2008-10-03 2017-01-31 Femasys, Inc. Contrast agent injection system for sonographic imaging
JP5820815B2 (ja) 2009-12-15 2015-11-24 インセプト・リミテッド・ライアビリティ・カンパニーＩｎｃｅｐｔ，Ｌｌｃ インプラントおよび生体分解性基準マーカー
US8871512B2 (en) 2010-10-27 2014-10-28 Empire Technology Development Llc Biocompatible polymerizable acrylate products and methods
CN103443138A (zh) * 2011-02-11 2013-12-11 阿克伦大学 聚（辛基氰基丙烯酸酯）-聚异丁烯聚合物共网络及其制备方法和应用
EP2656822B1 (en) * 2012-04-24 2014-12-03 Urogyn B.V. Applicator for delivering an occluding compound in a fallopian tube
NL2008860C2 (en) * 2012-05-23 2013-11-26 Urogyn B V Composition for use in occluding a body duct in a living creature.
WO2015175014A1 (en) * 2014-05-14 2015-11-19 The University Of Akron Method for the production of poly(2-octyl cyanoacrylate)-polyisobutylene co-network, and super initiators therefor
US9782433B2 (en) 2015-11-13 2017-10-10 The University Of Akron Co-network of high and low molecular weight 3-arm star cyanoacrylate-telechelic polyisobutylene and 2-octyl cyanoacrylate
US9603868B1 (en) 2015-11-13 2017-03-28 The University Of Akron Polymer adhesives comprising a low boiling point biocompatible solvent, high molecular weight multi-arm star cyanoacrylate-telechelic polyisobutylene and 2-octyl cyanoacrylate
CN106755267A (zh) * 2017-01-16 2017-05-31 电子科技大学 一种a‑氰基丙烯酸酯细胞毒性检测方法
EP4086294A1 (en) 2021-05-07 2022-11-09 Bostik SA Two-part curable composition
CN114392386A (zh) * 2022-02-11 2022-04-26 上海益思妙医疗器械有限公司 一种用于治疗静脉曲张的血管闭合组合物
CN116549708A (zh) * 2023-05-25 2023-08-08 卫纳塞德(北京)医疗科技有限公司 一种抗弯折医用胶及其制备方法

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2721858A (en) * 1954-03-10 1955-10-25 Eastman Kodak Co Method of making alpha-cyanoacrylates
US3142698A (en) * 1960-10-03 1964-07-28 Borden Co Cyanoacrylate esters
US3254111A (en) * 1960-12-09 1966-05-31 Eastman Kodak Co Esters of alpha-cyanoacrylic acid and process for the manufacture thereof
GB1130638A (en) * 1966-04-06 1968-10-16 Ici Ltd Preparation of -‡-cyanoacrylic esters
US3355482A (en) * 1966-06-20 1967-11-28 Eastman Kodak Co Stabilized cyanoacrylate adhesives
ES381202A1 (es) * 1969-06-27 1973-04-16 Nyegaard & Co As Un procedimiento para la preparacion de agentes de contras-te de rayos x.
US3654340A (en) * 1970-08-27 1972-04-04 Minnesota Mining & Mfg Cyanoacrylate monomer process
US3654239A (en) * 1970-11-20 1972-04-04 Eastman Kodak Co Process for the preparation of poly-(alpha-cyanoacrylates)
IE35430B1 (en) * 1971-01-06 1976-02-18 Intercontinental Chem Co Ltd High-viscosity cyanoacrylate adhesive compositions and processes for their preparation
US3940362A (en) * 1972-05-25 1976-02-24 Johnson & Johnson Cross-linked cyanoacrylate adhesive compositions
US3975422A (en) * 1972-11-21 1976-08-17 Johnson & Johnson Preparation of bis (2-cyanoacrylate)monomers
US4012402A (en) * 1974-10-04 1977-03-15 Johnson & Johnson Modified cyanoacrylate monomers and methods for preparation
JPS5753541Y2 (enExample) * 1978-01-28 1982-11-19
DE2909439A1 (de) * 1979-03-08 1980-09-18 Schering Ag Neue nichtionische roentgenkontrastmittel
US4847065A (en) * 1987-02-10 1989-07-11 Akimova Alla Y Composition for occlusion of ducts and cavities of human body
JPH01197464A (ja) 1988-02-01 1989-08-09 Matsumoto Seiyaku Kogyo Kk 多価α−シアノアクリレートの合成法とその組成物
CA2019669A1 (en) * 1989-11-21 1991-05-21 John Woods Anionically polymerizable monomers, polymers thereof, and use of such polymers in photoresists
EP0459617A1 (en) * 1990-04-27 1991-12-04 Three Bond Co., Ltd. Novel silicon containing alpha-cyanoacrylates
US5202352A (en) * 1990-08-08 1993-04-13 Takeda Chemical Industries, Ltd. Intravascular embolizing agent containing angiogenesis-inhibiting substance
JPH08505383A (ja) 1993-01-11 1996-06-11 ユーロタツクス・リミテツド ２−シアノアクリル酸エステルの製造方法及び該方法により製造されたエステルの接着剤としての使用
US5624669A (en) * 1993-03-31 1997-04-29 Tri-Point Medical Corporation Method of hemostatic sealing of blood vessels and internal organs
JPH0733726A (ja) 1993-07-21 1995-02-03 Toagosei Co Ltd 多価シアノアクリレートの製造方法
US5795331A (en) * 1994-01-24 1998-08-18 Micro Therapeutics, Inc. Balloon catheter for occluding aneurysms of branch vessels
BR9507927A (pt) * 1994-06-06 1997-11-11 Henkel Kgaa Processo para a preparação de bis-cianoacrilatos
CA2193968A1 (en) * 1994-06-28 1996-01-11 Jeffrey G. Clark Ph-modified biocompatible monomer and polymer compositions
US5504252A (en) * 1995-05-05 1996-04-02 Loctite Corporation Synthesis of cyanoacrylate esters by oxidation of aromatic selenyl cyanopropionates
WO1996039469A1 (de) 1995-06-06 1996-12-12 Henkel Kommanditgesellschaft Auf Aktien Cyanacrylat-klebstoff
US5667767A (en) * 1995-07-27 1997-09-16 Micro Therapeutics, Inc. Compositions for use in embolizing blood vessels
US5882334A (en) * 1995-12-04 1999-03-16 Target Therapeutics, Inc. Balloon/delivery catheter assembly with adjustable balloon positioning
US5702361A (en) * 1996-01-31 1997-12-30 Micro Therapeutics, Inc. Method for embolizing blood vessels
US5695480A (en) * 1996-07-29 1997-12-09 Micro Therapeutics, Inc. Embolizing compositions
US5925683A (en) * 1996-10-17 1999-07-20 Target Therapeutics, Inc. Liquid embolic agents
JPH10152650A (ja) * 1996-11-26 1998-06-09 Mitsubishi Chem Corp ２−シアノアクリレート系接着剤
CN1246032A (zh) * 1997-01-10 2000-03-01 医疗逻辑综合公司 含抗微生物剂的腈基丙烯酸酯组合物
GB9715241D0 (en) 1997-07-18 1997-09-24 Jeffree Martin A Device for treating aneurysms
US6538026B1 (en) * 1997-09-11 2003-03-25 Provasis Therapeutics, Inc. Compositions useful for remodeling body spaces
US6476069B2 (en) 1997-09-11 2002-11-05 Provasis Therapeutics Inc. Compositions for creating embolic agents and uses thereof
US6037366A (en) * 1997-09-11 2000-03-14 Prohold Medical Technologies, Inc. Composition for creating vascular occlusions
US6174919B1 (en) * 1998-02-18 2001-01-16 Closure Medical Corporation Cyanoacrylate compositions with vinyl terminated ester groups
US6051607A (en) * 1998-07-02 2000-04-18 Micro Therapeutics, Inc. Vascular embolizing compositions comprising ethyl lactate and methods for their use

Also Published As

Publication number Publication date
DE60305906D1 (de) 2006-07-20
EP1494999B1 (en) 2006-06-07
DE60305906T2 (de) 2007-01-18
ATE328865T1 (de) 2006-06-15
JP4504026B2 (ja) 2010-07-14
WO2003087042A1 (en) 2003-10-23
CA2481365A1 (en) 2003-10-23
US20030194389A1 (en) 2003-10-16
JP2005522505A (ja) 2005-07-28
EP1494999A1 (en) 2005-01-12
ES2261934T3 (es) 2006-11-16
US7341716B2 (en) 2008-03-11
CA2481365C (en) 2010-07-13

Similar Documents

Publication Publication Date Title
AU2003228516A1 (en) Occlusive composition comprising a poly (2-cyanoacrylate) monomer
BRPI0410078A (pt) uso de efetuadores de ciclases de glutaminila e glutamato
AU2001276721A1 (en) Salts of benzimidazole compound and use thereof
AU2003210430A1 (en) Cosmetic preparation
WO2000069470A3 (en) Improved cellular uptake of bioactive agents
IL161154A0 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
HK1049841A1 (zh) 新瞵酸二酰胺药物前体
GB2415142A (en) Porous matrix
AU7725596A (en) Antithrombotic diamines
AU2003225617A1 (en) Thiadiazolylpiperazine derivatives useful for treating or preventing pain
WO2004045372A3 (en) Cohesive demineralized bone compositions
EP2168962A3 (en) Phenylacetamides and their use as glucokinase modulators
AU2963400A (en) Improved controlled release compositions and method
WO2004056828A3 (en) Novel compounds and uses thereof
AU2003250471A1 (en) Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors
EP1480677B8 (en) Composition for stabilizing hyaluronic acid
BR0012696A (pt) Composição oftálmica
AU2001290480A1 (en) Cyclized benzamide neurokinin antagonists for use in therapy
AU2001263278A1 (en) Cyclic gmp-specific phosphodiesterase inhibitors
AU2002359150A1 (en) Therapeutic heterocycles
AU2001246999A1 (en) New neurokinin antagonists for use as medicaments
AU2003271811A1 (en) Novel derivatives of 4,4'-dithiobis-(3-aminobutane-1-sulphonates) and compositions containing same
AU2002248531A1 (en) Pyrazolopyriadine derivatives
AU5390900A (en) Potassium channel blocking agents
WO2002070638A3 (en) Essential oil from.coleus forskohlii, production process and use as antimicrobial agent

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase